Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs
HOME
/
Research Publications
/
Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs